Hubert Chen

Hubert Chen

Nessuna posizione attualmente

Patrimonio netto: 65 010 $ in data 31/03/2024

55 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Hubert C.
Chen
is a former Associate Director-Medical Sciences at Amgen, Inc. He also worked as a Senior Director-Clinical Research at Amylin Pharmaceuticals, Inc. and as a Vice President-Clinical Development at Aileron Therapeutics, Inc. Additionally, he served as an Assistant Clinical Professor at The University of California, San Francisco and as a Staff Research Investigator at The J.
David Gladstone Institutes.
He held the position of Vice President-Translational Medicine at Regulus Therapeutics, Inc. and Chief Medical & Scientific Officer at Pelican Inc. He later became the Chief Medical Officer at Metacrine, Inc. Currently, he is the President & Chief Scientific Officer at Forte Biosciences, Inc. Dr. Chen holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Stanford University.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
01/01/2024 93 405 ( 0.26% ) 65 010 $ 31/03/2024

Precedenti posizioni note di Hubert Chen

SocietàPosizioneFine
FORTE BIOSCIENCES, INC. President 15/03/2024
METACRINE, INC. Chief Tech/Sci/R&D Officer 31/12/2021
PFENEX INC. Chief Tech/Sci/R&D Officer 02/09/2018
AILERON THERAPEUTICS, INC. Corporate Officer/Principal 01/10/2014
REGULUS THERAPEUTICS INC. Corporate Officer/Principal 01/01/2012
Vedi nel dettaglio l'esperienza di Hubert Chen

Formazione di Hubert Chen

The Trustees of Columbia University in The City of New York Doctorate Degree
Stanford University Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Hubert Chen

Relazioni

100 +

Relazioni di 1° grado

11

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa5
AMGEN INC.

Health Technology

AILERON THERAPEUTICS, INC.

Health Technology

REGULUS THERAPEUTICS INC.

Health Technology

FORTE BIOSCIENCES, INC.

Health Technology

METACRINE, INC.

Health Technology

Aziende private3

Health Technology

Commercial Services

Health Technology

Vedi le connessioni aziendali